- Home
- RGNX vs BWFG Comparison
RGNX vs BWFG Comparison
Compare RGNX & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | BWFG |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 382.8M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RGNX | BWFG |
|---|---|---|
| Price | $8.76 | $50.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $28.75 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 501.7K | 37.3K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | 18.08 | ★ 261.79 |
| EPS | N/A | ★ 4.45 |
| Revenue | ★ $10,393,000.00 | $2,826,000.00 |
| Revenue This Year | $51.21 | $17.64 |
| Revenue Next Year | $19.08 | $6.21 |
| P/E Ratio | ★ N/A | $11.30 |
| Revenue Growth | ★ 126.48 | 43.96 |
| 52 Week Low | $6.89 | $32.19 |
| 52 Week High | $16.19 | $53.86 |
Technical Indicators
Market Signals| Indicator | RGNX | BWFG |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 51.63 |
| Support Level | $8.68 | $45.40 |
| Resistance Level | $9.29 | $51.05 |
| Average True Range (ATR) | 0.48 | 1.73 |
| MACD | 0.02 | -0.29 |
| Stochastic Oscillator | 28.57 | 53.03 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.